Amandeep S Mahal, MD
Urology · Omaha
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Urology Center PC · 43 clinicians in this group
Hospitals listed: Methodist Fremont Health · Methodist Hospital · Methodist Jennie Edmundson. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Mahal’s office to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Methodist Fremont HealthFremont, NEAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Methodist Health System, which runs 3 hospitals in 2 statesPatients rate it 4 of 5 · 66% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.168, Oct 2024 – Sep 2025
- Methodist Jennie EdmundsonCouncil Bluffs, IAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Methodist Health System, which runs 3 hospitals in 2 statesPatients rate it 4 of 5 · 73% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.518, Oct 2024 – Sep 2025
- The Nebraska Methodist HospitalOmaha, NEAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Methodist Health System, which runs 3 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Iatrogenic pneumothorax rate: 0.41 (0.23 to 0.59) · 9,430 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative hemorrhage or hematoma rate: 5.52 (4.37 to 6.68) · 3,212 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.408, Oct 2024 – Sep 2025
See every measure and the patient survey for Methodist Fremont Health
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 1 better, 5 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.63 to 1.53) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 79 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.1 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.7 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.5 · 170 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.6 · 40 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 816 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,687 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,607 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.4 (0.97 to 5.83) · 388 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.6 (0 to 3.3) · 145 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.54 (0.85 to 4.23) · 365 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.89 (0 to 17.23) · 150 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.67 (2.47 to 10.88) · 130 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.27) · 60 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.9 (0 to 1.99) · 1,264 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 73 cases | None | Apr 2023 – Mar 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 36 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.8 · 133 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.7 · 129 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -29.7 · 179 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.6 (8.8 to 15.2) · 899 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 292 cases | No different | Jan 2024 – Dec 2024 |
What patients said (427 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 67% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Methodist Jennie Edmundson
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 6 the same, 0 worse of 6 measures. Readmissions: 0 better, 10 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.518 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.94) · 521 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.72 to 1.53) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.69 (95.29 to 216.09) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.1 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 128 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.9 · 231 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 119 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,482 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.39) · 3,444 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,414 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.33 (2 to 6.66) · 549 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 153 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.09 (0.45 to 3.74) · 517 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.56 (0.58 to 18.54) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.19 (4.05 to 12.33) · 144 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.04 (0.54 to 3.55) · 134 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.63 (0 to 1.53) · 2,720 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 32 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.453 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.585 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.3 · 112 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -13.8 · 108 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -24.2 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -20.5 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 35 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 157 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (9.1 to 15.2) · 1,266 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 356 cases | No different | Jan 2024 – Dec 2024 |
What patients said (956 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
See every measure and the patient survey for The Nebraska Methodist Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 8 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Iatrogenic pneumothorax rateComplications and deaths | 0.41 (0.23 to 0.59) · 9,430 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 5.52 (4.37 to 6.68) · 3,212 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.408 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.72 (0.97 to 2.46) · 2,550 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 191.37 (147.65 to 235.1) · 144 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.6 · 208 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 239 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 577 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.7 · 646 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 281 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 5,027 cases | None | Jul 2024 – Jun 2025 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.13 to 0.49) · 10,276 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.95 (1.37 to 4.54) · 3,571 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.04 (0.81 to 3.27) · 2,249 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.01 (7.92 to 16.1) · 1,998 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.19 (0.75 to 5.63) · 2,123 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.35 (0.01 to 2.7) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.48 (0 to 1.02) · 7,904 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 283 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.544 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.493 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.812 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.828 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.7 · 255 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.2 · 809 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 2.8 · 236 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5.1 · 639 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8.8 · 649 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 833 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.1 to 7.1) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.9 (7.8 to 15.1) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7 · 255 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.4 · 175 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 371 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (10.6 to 16.9) · 1,304 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.1) · 1,935 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,588 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
Original Medicare doctor bills
$259,106
Medicare paid this office $259,106 for 570 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 225 | $23,470 | $88 |
| Surgical repair of vaginal defect using an endoscope | 31 | $21,361 | $668 |
| Detection test by nucleic acid for organism, amplified probe technique | 45 | $21,096 | $34 |
| Short return visit (20+ min) | 229 | $16,634 | $58 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 60 | $15,597 | $260 |
See all 43 services
| Return visit (30+ min) | 225 | $23,470 | $88 |
| Surgical repair of vaginal defect using an endoscope | 31 | $21,361 | $668 |
| Detection test by nucleic acid for organism, amplified probe technique | 45 | $21,096 | $34 |
| Short return visit (20+ min) | 229 | $16,634 | $58 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 60 | $15,597 | $260 |
| New patient visit (45+ min) | 142 | $14,458 | $102 |
| Repair of herniated rectum into vaginal wall | 40 | $10,686 | $267 |
| Creation of sling around urethra in female to control leakage | 28 | $10,042 | $359 |
| Insertion of sacral nerve neurostimulator electrode array | 25 | $9,687 | $255 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 44 | $9,563 | $69 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 62 | $8,825 | $42 |
| Detection test for candida species (yeast), amplified probe technique | 45 | $8,116 | $34 |
| Insertion of device into abdomen with pressure and urine flow rate study | 60 | $8,075 | $135 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 36 | $6,355 | $118 |
| Insertion of temporary bladder tube | 135 | $4,267 | $27 |
| New patient visit (30+ min) | 42 | $3,210 | $76 |
| Pelvic exam | 162 | $2,939 | $16 |
| Diagnostic exam of bladder and urethra using an endoscope | 59 | $2,736 | $46 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 18 | $2,478 | $138 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 45 | $1,651 | $34 |
| Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | 45 | $1,651 | $34 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 45 | $1,651 | $34 |
| Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | 45 | $1,651 | $34 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 45 | $1,651 | $34 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 45 | $1,651 | $34 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 45 | $1,651 | $34 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 45 | $1,651 | $34 |
| Detection test for gardnerella vaginalis (bacteria), amplified probe technique | 40 | $1,479 | $34 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 19 | $1,089 | $35 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 39 | $905 | $23 |
| Detection of mycoplasma genitalium by dna or rna probe | 20 | $757 | $34 |
| Short return visit | 18 | $753 | $40 |
| Ultrasound measurement of bladder capacity after voiding | 83 | $660 | $7 |
| Fitting and insertion of vaginal support device | 11 | $571 | $52 |
| Pessary, reusable, non rubber, any type | 11 | $542 | $49 |
| Automated urinalysis test | 198 | $528 | $2 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 34 | $437 | $12 |
| Imaging guidance for procedure, 60 minutes or less | 23 | $374 | $11 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 12 | $347 | $29 |
| Psa (prostate specific antigen) measurement, total | 17 | $306 | $18 |
| Electronic assessment of bladder emptying | 57 | $290 | $5 |
| Testosterone (hormone) level, total | 11 | $278 | $25 |
| Insertion of needle into vein for collection of blood sample | 26 | $225 | $9 |
Procedures Medicare counted
| Removal of the uterus | 19 | More than 92% of doctors who do this |
Who their Medicare patients are
570 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 15% · Women 88% · Also on Medicaid 6% · Health risk score 1.11. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 75% · Depression 29% · Chronic kidney disease 26% · Diabetes 25% · Coronary heart disease 23% · Cancer 20% · Atrial fibrillation 18% · Heart failure 14% · COPD 13% · Stroke 8% · Dementia 6%.
The office billed $1,162,216, Medicare allowed $323,418 and paid $259,106; for 6,934 services of 109 kinds; $10,032 of it was for drugs given in the office and $249,074 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 570 | 6,934 | 76 | 1.11 | $1,162,216 | $259,106 |
| 2023 | 510 | 3,541 | 75 | 1.07 | $989,862 | $206,363 |
| 2022 | 487 | 3,909 | 75 | 1.15 | $953,813 | $191,031 |
| 2021 | 431 | 3,110 | 75 | 1.19 | $695,204 | $153,933 |
| 2020 | 364 | 2,823 | 74 | 1.11 | $630,951 | $135,421 |
| 2019 | 365 | 2,454 | 74 | 1.19 | $591,880 | $126,387 |
| 2018 | 316 | 2,334 | 73 | 1.13 | $596,450 | $119,338 |
| 2017 | 168 | 1,030 | 72 | 1.33 | $201,947 | $45,218 |
| 2016 | 109 | 171 | 72 | 1.23 | $43,166 | $10,681 |
| 2015 | 84 | 132 | 73 | 1.30 | $33,691 | $8,801 |
| 2014 | 11 | 18 | 71 | 0.85 | $4,210 | $1,147 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 40 services
| Surgical repair of vaginal defect using an endoscope | 31 | $20,624 | $645 |
| Short return visit (20+ min) | 239 | $19,613 | $59 |
| Return visit (30+ min) | 159 | $17,794 | $91 |
| Creation of sling around urethra in female to control leakage | 48 | $17,769 | $370 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 60 | $15,712 | $262 |
| New patient visit (45+ min) | 105 | $11,187 | $107 |
| Repair of herniated rectum into vaginal wall | 39 | $10,468 | $262 |
| Insertion of sacral nerve neurostimulator electrode array | 24 | $8,150 | $247 |
| Insertion of device into abdomen with pressure and urine flow rate study | 60 | $8,077 | $135 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 44 | $7,504 | $46 |
| Detection test by nucleic acid for organism, amplified probe technique | 13 | $6,259 | $34 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 40 | $6,038 | $121 |
| Partial removal of uterus, tubes, and/or ovaries with retention of cervix using an endoscope, 250.0 g or less | 15 | $5,032 | $335 |
| Insertion of temporary bladder tube | 136 | $4,598 | $29 |
| New patient visit (30+ min) | 58 | $3,574 | $62 |
| Detection test for candida species (yeast), amplified probe technique | 13 | $2,407 | $34 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 21 | $1,738 | $83 |
| Diagnostic exam of bladder and urethra using an endoscope | 34 | $1,525 | $45 |
| Diagnostic exam of bladder and urethra using an endoscope | 11 | $1,401 | $127 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 45 | $1,028 | $23 |
| Pessary, reusable, non rubber, any type | 14 | $845 | $53 |
| Short return visit | 18 | $704 | $39 |
| Fitting and insertion of vaginal support device | 13 | $703 | $50 |
| Automated urinalysis test | 191 | $537 | $2 |
| Ultrasound measurement of bladder capacity after voiding | 62 | $509 | $7 |
| Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | 13 | $481 | $34 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 13 | $481 | $34 |
| Detection test for gardnerella vaginalis (bacteria), amplified probe technique | 13 | $481 | $34 |
| Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | 13 | $481 | $34 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 13 | $481 | $34 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 13 | $481 | $34 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 13 | $481 | $34 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 13 | $481 | $34 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 13 | $481 | $34 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 15 | $439 | $29 |
| Short return visit (20+ min) | 11 | $389 | $32 |
| Imaging guidance for procedure, 60 minutes or less | 23 | $368 | $11 |
| Psa (prostate specific antigen) measurement, total | 19 | $342 | $18 |
| Electronic assessment of bladder emptying | 61 | $313 | $5 |
| Insertion of needle into vein for collection of blood sample | 19 | $176 | $8 |
2022: 29 services
| Short return visit (20+ min) | 272 | $25,462 | $61 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 80 | $21,663 | $271 |
| Surgical repair of vaginal defect using an endoscope | 27 | $19,050 | $706 |
| Creation of sling around urethra in female to control leakage | 49 | $18,635 | $373 |
| Insertion of device into abdomen with pressure and urine flow rate study | 80 | $11,101 | $139 |
| New patient visit (30+ min) | 144 | $10,169 | $71 |
| Repair of herniated rectum into vaginal wall | 34 | $8,663 | $241 |
| Insertion of sacral nerve neurostimulator electrode array | 15 | $5,978 | $260 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 28 | $4,795 | $123 |
| Insertion of temporary bladder tube | 144 | $4,744 | $29 |
| Diagnostic exam of bladder and urethra using an endoscope | 31 | $3,219 | $104 |
| New patient visit (45+ min) | 30 | $2,987 | $100 |
| Suture closure of vagina and vaginal opening | 13 | $2,582 | $184 |
| Return visit (30+ min) | 25 | $2,482 | $95 |
| Short return visit | 55 | $2,419 | $39 |
| Diagnostic exam of bladder and urethra using an endoscope | 37 | $1,735 | $47 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 63 | $1,468 | $23 |
| Short return visit (20+ min) | 20 | $1,057 | $50 |
| Ct scan of abdomen and pelvis without contrast | 12 | $954 | $79 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 12 | $883 | $74 |
| Automated urinalysis test | 188 | $551 | $2 |
| Ultrasound measurement of bladder capacity after voiding | 63 | $511 | $7 |
| Electronic assessment of bladder emptying | 78 | $399 | $5 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 11 | $330 | $30 |
| Imaging guidance for procedure, 60 minutes or less | 21 | $325 | $11 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $275 | $17 |
| Insertion of temporary bladder tube | 13 | $264 | $18 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 12 | $117 | $0 |
| Insertion of needle into vein for collection of blood sample | 11 | $32 | $3 |
2021: 31 services
| Short return visit (20+ min) | 247 | $24,571 | $63 |
| Creation of sling around urethra in female to control leakage | 37 | $14,585 | $394 |
| Surgical repair of vaginal defect using an endoscope | 19 | $13,417 | $706 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 37 | $10,111 | $273 |
| New patient visit (45+ min) | 85 | $9,467 | $111 |
| Repair of herniated rectum into vaginal wall | 27 | $7,131 | $255 |
| New patient visit (30+ min) | 80 | $6,489 | $81 |
| Insertion of device into abdomen with pressure and urine flow rate study | 48 | $6,441 | $134 |
| Insertion of sacral nerve neurostimulator electrode | 11 | $5,798 | $483 |
| Insertion of temporary bladder tube | 133 | $5,165 | $32 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 26 | $3,798 | $123 |
| Return visit (30+ min) | 39 | $3,439 | $86 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 11 | $3,118 | $283 |
| Diagnostic exam of bladder and urethra using an endoscope | 43 | $1,846 | $43 |
| New patient visit (45+ min) | 12 | $1,147 | $96 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 12 | $1,135 | $87 |
| Short return visit (20+ min) | 21 | $1,078 | $43 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 36 | $860 | $24 |
| Short return visit | 20 | $781 | $39 |
| Fitting and insertion of vaginal support device | 14 | $757 | $54 |
| Detection test by nucleic acid for multiple organisms, direct probe(s) technique | 14 | $699 | $44 |
| Pessary, reusable, non rubber, any type | 12 | $566 | $47 |
| Automated urinalysis test | 191 | $554 | $2 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 12 | $401 | $31 |
| Ultrasound measurement of bladder capacity after voiding | 52 | $349 | $6 |
| Imaging guidance for procedure, 60 minutes or less | 17 | $274 | $11 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $272 | $17 |
| Electronic assessment of bladder emptying | 49 | $255 | $5 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13 | $130 | $0 |
| Blood creatinine level | 13 | $67 | $5 |
| Insertion of needle into vein for collection of blood sample | 11 | $33 | $3 |
2020: 30 services
| Creation of sling around urethra in female to control leakage | 35 | $15,586 | $445 |
| Short return visit (20+ min) | 207 | $14,711 | $52 |
| Surgical repair of vaginal defect using an endoscope | 11 | $8,230 | $748 |
| New patient visit (45+ min) | 70 | $7,918 | $113 |
| Repair of herniated rectum into vaginal wall | 27 | $7,657 | $284 |
| Insertion of sacral nerve neurostimulator electrode | 15 | $7,481 | $499 |
| Return visit (30+ min) | 81 | $7,063 | $76 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 23 | $6,156 | $268 |
| Insertion of device into abdomen with pressure and urine flow rate study | 35 | $3,897 | $111 |
| Insertion of temporary bladder tube | 98 | $3,765 | $30 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 24 | $3,283 | $126 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 12 | $2,561 | $213 |
| Suture closure of vagina and vaginal opening | 11 | $2,213 | $201 |
| Diagnostic exam of bladder and urethra using an endoscope | 19 | $1,990 | $105 |
| New patient visit (30+ min) | 22 | $1,563 | $71 |
| Diagnostic exam of bladder and urethra using an endoscope | 31 | $1,537 | $50 |
| Detection test by nucleic acid for multiple organisms, direct probe(s) technique | 31 | $1,432 | $41 |
| Short return visit (20+ min) | 25 | $1,375 | $37 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 14 | $1,290 | $92 |
| New patient visit (45+ min) | 11 | $1,100 | $100 |
| Simple bladder irrigation and/or instillation | 11 | $947 | $56 |
| Fitting and insertion of vaginal support device | 13 | $704 | $47 |
| Pessary, reusable, non rubber, any type | 13 | $683 | $46 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 24 | $670 | $28 |
| Automated urinalysis test | 182 | $564 | $2 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 15 | $480 | $32 |
| Imaging guidance for procedure, 60 minutes or less | 18 | $310 | $12 |
| Ultrasound measurement of bladder capacity after voiding | 40 | $298 | $7 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $257 | $17 |
| Electronic assessment of bladder emptying | 33 | $179 | $5 |
2019: 18 services
| Return visit (30+ min) | 129 | $13,958 | $75 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 58 | $13,807 | $238 |
| Creation of sling around urethra in female to control leakage | 28 | $10,897 | $389 |
| New patient visit (45+ min) | 77 | $9,189 | $119 |
| Short return visit (20+ min) | 130 | $8,817 | $53 |
| Insertion of device into abdomen with pressure and urine flow rate study | 57 | $5,677 | $100 |
| Repair of herniated rectum into vaginal wall | 20 | $5,396 | $270 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 26 | $3,914 | $126 |
| Insertion of temporary bladder tube | 99 | $3,666 | $33 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 57 | $1,442 | $25 |
| New patient visit (30+ min) | 16 | $1,292 | $81 |
| Diagnostic exam of bladder and urethra using an endoscope | 13 | $1,273 | $98 |
| Detection test by nucleic acid for multiple organisms, direct probe(s) technique | 20 | $1,048 | $44 |
| Diagnostic exam of bladder and urethra using an endoscope | 15 | $745 | $50 |
| Fitting and insertion of vaginal support device | 13 | $650 | $46 |
| Automated urinalysis test | 165 | $531 | $2 |
| Ultrasound measurement of bladder capacity after voiding | 41 | $438 | $9 |
| Electronic assessment of bladder emptying | 59 | $315 | $5 |
2018: 21 services
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 70 | $15,683 | $218 |
| Return visit (30+ min) | 117 | $12,029 | $74 |
| New patient visit (45+ min) | 83 | $9,220 | $111 |
| Creation of sling around urethra in female to control leakage | 27 | $9,178 | $340 |
| Surgical repair of vaginal defect using an endoscope | 13 | $7,941 | $611 |
| Short return visit (20+ min) | 98 | $6,523 | $48 |
| Insertion of device into abdomen with pressure and urine flow rate study | 70 | $5,708 | $79 |
| Repair of herniated rectum into vaginal wall | 19 | $5,173 | $272 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 12 | $4,692 | $391 |
| Insertion of temporary bladder tube | 103 | $4,536 | $33 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 69 | $1,712 | $25 |
| Detection test by nucleic acid for multiple organisms, direct probe(s) technique | 30 | $1,650 | $49 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 11 | $1,369 | $124 |
| Long return visit (40+ min) | 12 | $1,364 | $105 |
| Diagnostic exam of bladder and urethra using an endoscope | 21 | $1,176 | $56 |
| New patient visit (30+ min) | 18 | $1,168 | $65 |
| Fitting and insertion of vaginal support device | 20 | $1,010 | $48 |
| Short return visit | 24 | $879 | $28 |
| Automated urinalysis test | 174 | $708 | $3 |
| Electronic assessment of bladder emptying | 67 | $381 | $6 |
| Ultrasound measurement of bladder capacity after voiding | 32 | $323 | $9 |
2017: 16 services
| Creation of sling around urethra in female to control leakage | 11 | $4,052 | $368 |
| New patient visit (45+ min) | 33 | $3,843 | $116 |
| Return visit (30+ min) | 31 | $2,940 | $77 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 13 | $2,915 | $224 |
| Short return visit (20+ min) | 27 | $1,626 | $52 |
| New patient visit (45+ min) | 16 | $1,482 | $93 |
| Insertion of temporary bladder tube | 33 | $1,353 | $34 |
| Insertion of device into abdomen with pressure and urine flow rate study | 13 | $1,037 | $80 |
| Diagnostic exam of bladder and urethra using an endoscope | 11 | $741 | $67 |
| Short return visit | 17 | $528 | $31 |
| Ultrasound measurement of bladder capacity after voiding | 23 | $360 | $13 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 13 | $348 | $27 |
| Automated urinalysis test | 77 | $311 | $3 |
| Short return visit (20+ min) | 11 | $223 | $20 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $188 | $14 |
| Electronic assessment of bladder emptying | 14 | $85 | $6 |
2016: 4 services
| New patient visit (45+ min) | 43 | $4,679 | $109 |
| New patient visit (30+ min) | 26 | $1,560 | $60 |
| Short return visit (20+ min) | 16 | $729 | $46 |
| Electronic assessment of bladder emptying | 12 | $57 | $5 |
2015: 2 services
| New patient visit (45+ min) | 34 | $3,816 | $112 |
| Short return visit (20+ min) | 22 | $1,000 | $45 |
Medicaid work
$627 in 2024
Medicaid paid $627 for 32 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 18 | $441 |
| Short return visit (20+ min) | 14 | $186 |
| 2024 | 32 | 2 | 17 | $627 |
| 2023 | 42 | 2 | 14 | $852 |
| 2022 | 79 | 3 | 17 | $2,478 |
| 2021 | 81 | 2 | 17 | $1,247 |
| 2020 | 18 | 1 | 13 | $265 |
| 2018 | 32 | 1 | 14 | $60 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 28 | $824 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 14 | $29 |
2022
| Short return visit (20+ min) | 50 | $1,530 |
| New patient visit (30+ min) | 15 | $932 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 14 | $16 |
2021
| Short return visit (20+ min) | 67 | $1,223 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 14 | $25 |
2020
| Short return visit (20+ min) | 18 | $265 |
2018
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 32 | $60 |
Drugs they prescribed that Part D paid
$297,608
Pharmacies billed $297,608 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
826 generic and 444 brand-name prescriptions · $297,608 in drug cost · 218 antibiotic prescriptions to 112 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 216 | $149,552 | $692 |
| Myrbetriq | 203 | $112,421 | $554 |
| Methenamine Hippurate | 235 | $7,466 | $32 |
| Trospium Chloride | 126 | $7,386 | $59 |
| Estradiol | 62 | $4,935 | $80 |
See all 20 drugs
| Gemtesa | 216 | $149,552 | $692 |
| Myrbetriq | 203 | $112,421 | $554 |
| Methenamine Hippurate | 235 | $7,466 | $32 |
| Trospium Chloride | 126 | $7,386 | $59 |
| Estradiol | 62 | $4,935 | $80 |
| Clindamycin Phosphate | 11 | $2,028 | $184 |
| Nitrofurantoin | 45 | $1,785 | $40 |
| Trospium Chloride Er | 17 | $1,652 | $97 |
| Nitrofurantoin Mono-Macro | 62 | $1,348 | $22 |
| Solifenacin | 19 | $621 | $33 |
| Tolterodine Tartrate Er | 11 | $612 | $56 |
| Oxybutynin Chloride | 25 | $420 | $17 |
| Clobetasol Propionate | 14 | $398 | $28 |
| Oxybutynin Chloride Er | 14 | $167 | $12 |
| Sulfamethoxazole-Trimethoprim | 64 | $162 | $3 |
| Cefdinir | 12 | $147 | $12 |
| Tamsulosin | 31 | $91 | $3 |
| Fluconazole | 18 | $82 | $5 |
| Ciprofloxacin | 15 | $63 | $4 |
| Cephalexin | 11 | $63 | $6 |
Year by year
| 2024 | 1,270 | 318 | None | 35% | $297,608 |
| 2023 | 1,038 | 283 | None | None | $254,073 |
| 2022 | 974 | 248 | 2% (16) | 38% | $194,362 |
| 2021 | 794 | 239 | 3% (22) | None | $137,882 |
| 2020 | 634 | 187 | 2% (11) | None | $94,926 |
| 2019 | 516 | 152 | 3% (14) | 36% | $63,398 |
| 2018 | 337 | 128 | 7% (23) | 25% | $36,495 |
| 2017 | 180 | 75 | 6% (11) | None | $25,416 |
| 2016 | 186 | 76 | None | None | $25,602 |
| 2015 | 135 | 67 | 9% (12) | 29% | $14,458 |
| 2014 | 56 | 29 | None | 38% | $4,314 |
| 2013 | 77 | 34 | 25% (19) | None | $2,864 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Myrbetriq | 235 | $119,029 | $507 |
| Gemtesa | 165 | $105,998 | $642 |
| Methenamine Hippurate | 144 | $5,922 | $41 |
| Trospium Chloride | 63 | $4,683 | $74 |
| Estradiol | 41 | $3,771 | $92 |
| Solifenacin | 21 | $2,459 | $117 |
| Nitrofurantoin | 38 | $1,590 | $42 |
| Oxybutynin Chloride Er | 22 | $1,209 | $55 |
| Oxybutynin Chloride | 42 | $1,169 | $28 |
| Nitrofurantoin Mono-Macro | 50 | $716 | $14 |
| Estradiol (Once Weekly) | 12 | $597 | $50 |
| Sulfamethoxazole-Trimethoprim | 65 | $395 | $6 |
| Clobetasol Propionate | 13 | $292 | $22 |
| Tamsulosin | 19 | $212 | $11 |
| Cefdinir | 17 | $172 | $10 |
2022: 20 drugs
| Myrbetriq | 151 | $85,508 | $566 |
| Gemtesa | 145 | $75,968 | $524 |
| Methenamine Hippurate | 121 | $5,767 | $48 |
| Trospium Chloride | 72 | $4,993 | $69 |
| Estradiol | 38 | $3,195 | $84 |
| Tolterodine Tartrate Er | 11 | $1,596 | $145 |
| Nitrofurantoin | 52 | $1,547 | $30 |
| Solifenacin | 15 | $1,263 | $84 |
| Oxybutynin Chloride Er | 25 | $1,086 | $43 |
| Oxybutynin Chloride | 47 | $986 | $21 |
| Clobetasol Propionate | 13 | $752 | $58 |
| Nitrofurantoin Mono-Macro | 41 | $724 | $18 |
| Estradiol (Once Weekly) | 12 | $601 | $50 |
| Tamsulosin | 27 | $440 | $16 |
| Cefdinir | 19 | $424 | $22 |
| Cephalexin | 27 | $315 | $12 |
| Sulfamethoxazole-Trimethoprim | 45 | $309 | $7 |
| Amitriptyline | 12 | $113 | $9 |
| Fluconazole | 12 | $107 | $9 |
| Ciprofloxacin | 15 | $70 | $5 |
2021: 21 drugs
| Myrbetriq | 158 | $86,433 | $547 |
| Gemtesa | 37 | $17,249 | $466 |
| Toviaz | 12 | $5,295 | $441 |
| Methenamine Hippurate | 80 | $4,776 | $60 |
| Estradiol | 34 | $4,456 | $131 |
| Trospium Chloride | 51 | $3,057 | $60 |
| Nitrofurantoin | 45 | $1,632 | $36 |
| Oxybutynin Chloride Er | 28 | $1,376 | $49 |
| Tolterodine Tartrate Er | 12 | $1,192 | $99 |
| Nitrofurantoin Mono-Macro | 65 | $1,051 | $16 |
| Clobetasol Propionate | 13 | $838 | $64 |
| Oxybutynin Chloride | 28 | $660 | $24 |
| Tamsulosin | 17 | $383 | $23 |
| Cefdinir | 19 | $319 | $17 |
| Metronidazole | 14 | $186 | $13 |
| Cephalexin | 25 | $180 | $7 |
| Fluconazole | 18 | $143 | $8 |
| Sulfamethoxazole-Trimethoprim | 29 | $142 | $5 |
| Amitriptyline | 17 | $122 | $7 |
| Hydrocodone-Acetaminophen | 12 | $94 | $8 |
| Ciprofloxacin | 13 | $43 | $3 |
2020: 14 drugs
| Myrbetriq | 149 | $65,331 | $438 |
| Toviaz | 20 | $6,759 | $338 |
| Methenamine Hippurate | 43 | $2,624 | $61 |
| Nitrofurantoin | 44 | $1,924 | $44 |
| Oxybutynin Chloride | 66 | $1,204 | $18 |
| Oxybutynin Chloride Er | 26 | $1,118 | $43 |
| Solifenacin | 12 | $1,026 | $86 |
| Nitrofurantoin Mono-Macro | 35 | $855 | $24 |
| Clobetasol Propionate | 11 | $329 | $30 |
| Fluconazole | 23 | $303 | $13 |
| Cefdinir | 16 | $266 | $17 |
| Cephalexin | 44 | $225 | $5 |
| Sulfamethoxazole-Trimethoprim | 25 | $121 | $5 |
| Metronidazole | 13 | $67 | $5 |
2019: 14 drugs
| Myrbetriq | 80 | $32,755 | $409 |
| Vesicare | 15 | $6,186 | $412 |
| Toviaz | 17 | $5,479 | $322 |
| Nitrofurantoin | 49 | $2,376 | $48 |
| Trospium Chloride | 24 | $2,321 | $97 |
| Oxybutynin Chloride | 64 | $1,734 | $27 |
| Methenamine Hippurate | 13 | $1,259 | $97 |
| Oxybutynin Chloride Er | 20 | $948 | $47 |
| Nitrofurantoin Mono-Macro | 30 | $631 | $21 |
| Clobetasol Propionate | 11 | $431 | $39 |
| Cephalexin | 34 | $202 | $6 |
| Ciprofloxacin | 18 | $75 | $4 |
| Sulfamethoxazole-Trimethoprim | 19 | $65 | $3 |
| Fluconazole | 12 | $64 | $5 |
2018: 10 drugs
| Myrbetriq | 46 | $22,898 | $498 |
| Oxybutynin Chloride Er | 24 | $1,589 | $66 |
| Oxybutynin Chloride | 37 | $1,058 | $29 |
| Trospium Chloride | 19 | $901 | $47 |
| Nitrofurantoin Mono-Macro | 16 | $598 | $37 |
| Fluconazole | 20 | $232 | $12 |
| Cephalexin | 20 | $180 | $9 |
| Ibuprofen | 17 | $115 | $7 |
| Sulfamethoxazole-Trimethoprim | 22 | $85 | $4 |
| Ciprofloxacin | 20 | $81 | $4 |
2017: 3 drugs
| Myrbetriq | 24 | $9,726 | $405 |
| Tamsulosin | 16 | $458 | $29 |
| Cephalexin | 15 | $106 | $7 |
2016: 6 drugs
| Detrol La | 12 | $3,742 | $312 |
| Premarin | 11 | $3,271 | $297 |
| Trospium Chloride | 21 | $2,405 | $115 |
| Tamsulosin | 19 | $875 | $46 |
| Oxybutynin Chloride Er | 20 | $647 | $32 |
| Finasteride | 17 | $117 | $7 |
2015: 4 drugs
| Premarin | 12 | $3,117 | $260 |
| Trospium Chloride | 15 | $2,809 | $187 |
| Oxybutynin Chloride Er | 15 | $516 | $34 |
| Tamsulosin | 21 | $340 | $16 |
2014: 1 drug
| Medroxyprogesterone Acetate | 11 | $294 | $27 |
2013: 2 drugs
| Oxycodone-Acetaminophen | 15 | $135 | $9 |
| Ibuprofen | 18 | $102 | $6 |
Money from drug and device companies
$322 in 2025
| 2025 | 9 | 14 | None | $322 |
| 2024 | 12 | 31 | None | $863 |
| 2023 | 8 | 32 | $5,803 | $8,145 |
| 2022 | 9 | 26 | $7,315 | $7,951 |
| 2021 | 8 | 52 | $10,050 | $13,321 |
| 2020 | 7 | 15 | None | $526 |
| 2019 | 5 | 34 | None | $2,285 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Urogen Pharma | Jelmyto | $78 | 3 payments
|
| Novartis Pharmaceuticals | Pluvicto | $58 | 2 payments
|
| Medtronic | Interstim | $42 | 2 payments
|
| Valencia Technologies | Ecoin Device Kit | $33 | 1 payment
|
| Boston Scientific | Upsylon | $32 | 2 payments
|
| Sumitomo Pharma America | Gemtesa | $25 | 1 payment
|
See all 14 published payments
| Novartis Pharmaceuticals | Meals · 2025-10-28 | Pluvicto | $25 |
| Medtronic | Meals · 2025-08-13 | Interstim | $25 |
| Sumitomo Pharma America | Meals · 2025-07-30 | Gemtesa | $25 |
| Novartis Pharmaceuticals | Meals · 2025-07-20 | Pluvicto | $33 |
| Boston Scientific | Meals · 2025-06-26 | Solyx Sis System | $14 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-06-19 | Nubeqa | $17 |
| Abbvie | Meals · 2025-06-16 | Botox | $20 |
| Valencia Technologies | Meals · 2025-05-07 | Ecoin Device Kit | $33 |
| Urogen Pharma | Meals · 2025-05-05 | Jelmyto | $27 |
| Urogen Pharma | Meals · 2025-03-27 | Jelmyto | $22 |
| Alnylam Pharmaceuticals | Meals · 2025-03-14 | Givlaari | $19 |
| Urogen Pharma | Meals · 2025-02-25 | Jelmyto | $29 |
| Boston Scientific | Meals · 2025-02-12 | Upsylon | $18 |
| Medtronic | Meals · 2025-01-15 | Interstim | $17 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $863
| Caldera Medical | Desara | $205 | 1 payment
|
| Axonics | Axonics | $199 | 3 payments
|
| Abbvie | Botox | $144 | 13 payments
|
| Sumitomo Pharma America | Gemtesa | $59 | 4 payments
|
| Novartis Pharmaceuticals | Pluvicto | $56 | 2 payments
|
| Boston Scientific | Advantage System | $56 | 1 payment
|
| Bluewind Medical | Revi | $37 | 1 payment
|
| Medtronic | Interstim | $30 | 2 payments
|
| Conmed | Airseal | $29 | 1 payment
|
| Ferring Pharmaceuticals | Adstiladrin | $19 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $16 | 1 payment
|
| Amgen | Evenity | $14 | 1 payment
|
2023: $8,145
| Axonics | Axonics | $7,436 | 22 payments
|
| Valencia Technologies | Ecoin Device Kit | $542 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $59 | 4 payments
|
| Caldera Medical | Desara | $39 | 1 payment
|
| Abbvie | Botox | $23 | 1 payment
|
| Coloplast | Porges Coloplast | $16 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $15 | 1 payment
|
| Blue Earth Diagnostics | Posluma | $15 | 1 payment
|
2022: $7,951
| Axonics | Axonics | $7,528 | 11 payments
|
| Caldera Medical | Desara | $144 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $140 | 5 payments
|
| Abbvie | Botox | $57 | 4 payments
|
| Boston Scientific | Rezum Generator | $20 | 1 payment
|
| Myovant Sciences | Orgovyx | $19 | 1 payment
|
| TOLMAR Pharmaceuticals | Eligard | $16 | 1 payment
|
| TherapeuticsMD | Annovera | $14 | 1 payment
|
| Allergan | Botox | $12 | 1 payment
|
2021: $13,321
| Axonics | Axonics R-Snm System | $13,124 | 40 payments
|
| Astellas Pharma US | Myrbetriq | $67 | 4 payments
|
| AbbVie | Lupron Depot | $37 | 2 payments
|
| Coloplast | Altis | $31 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Xofigo | $23 | 1 payment
|
| Myovant Sciences | Orgovyx | $13 | 1 payment
|
| Medline Industries | None | $13 | 1 payment
|
| Allergan | Botox | $13 | 1 payment
|
2020: $526
| Axonics Modulation Technologies | Axonics R-Snm System | $316 | 8 payments
|
| Medtronic USA | Interstim | $69 | 1 payment
|
| Dornier MedTech America | Consumables & Accessories | $62 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $31 | 2 payments
|
| KARL STORZ Endoscopy-America | Cmos Videcysturethroscope US | $23 | 1 payment
|
| Allergan | Botox | $12 | 1 payment
|
| Boston Scientific | General - Female Sui | $12 | 1 payment
|
2019: $2,285
| Medtronic USA | Interstim | $2,220 | 30 payments
|
| Astellas Pharma US | Myrbetriq | $20 | 1 payment
|
| Duchesnay USA | Osphena | $17 | 1 payment
|
| Pfizer | Premarin | $14 | 1 payment
|
| Allergan | Botox | $13 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Axonics, Inc. · Foramen Finder Study · 2024 | Their institution | $28,281 |
| Boston Scientific Corporation · Ff Study · 2025 | Their institution | $2,200 |
Professional record
- NPI
- 1588983266
- Licence
- IA R-8861, NE 29590
- Trained
- Creighton University School of Medicine, 2010
- Group
- Urology Center PC
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207VF0040X (207VF0040X)
- Mailing address
- 10707 Pacific St Ste 101, Omaha, NE, 68114
- NPI first listed
- 2010-05-20
- NPI last updated
- 2022-07-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305